Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General
  • News

Presage Biosciences Announces New Pharma Partnership With AstraZeneca To Evaluate Novel Immuno-Oncology Drug Combinations With CIVO Technology

By Benzinga Newsdesk
November 30, 9:05 AM
Presage Biosciences, a pioneering translational oncology company whose mission is to use CIVO and spatial molecular profiling to understand the complexity of drug response in the tumor microenvironment (TME), has entered

AZN

Read More
3 minute read
  • Biotech
  • General
  • News

Cibus Announces New Publication: Industrial Scale Gene Editing In Brassica Napus

By Benzinga Newsdesk
November 30, 9:02 AM
In the peer reviewed publication, the International Journal of Plant Biology, Cibus provides two case studies of improving oleic oil content and developing pod shatter reduction in Brassica napus (canola,

CBUS

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News

Desktop Health Announces First Patients Treated With FDA-Cleared CMFlex – An Off-The-Shelf 3D Printed Synthetic Bone Graft Product Pioneered By Dimension Inx On The 3D-Bioplotter

By Benzinga Newsdesk
November 29, 5:31 PM
Chicago-based Dimension Inx, a regenerative therapeutics company, has now had its innovative CMFlex material implanted in multiple patientsCMFlex is an off-the-shelf, customizable bone graft material indicated for

DM

Read More
1 minute read
  • Biotech
  • General
  • Global
  • News

Health Canada Grants Market Authorization For KALYDECO For Eligible Children With Cystic Fibrosis Ages 2 Months and Older

By Benzinga Newsdesk
November 29, 3:03 PM
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced that Health Canada has granted Market Authorization for the expanded use of PrKALYDECO® (ivacaftor) for the treatment of cystic fibrosis

VRTX

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Management
  • Markets
  • Movers
  • News

Why Is Eagle Pharmaceuticals Stock Trading Lower Today?

By Vandana Singh
November 29, 2:46 PM
Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) Scott Tarriff, founder, president, and Chief Executive Officer, announced his resignation and retirement, 

EGRX

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

AbbVie’s Lung Cancer Study Shows Encouraging Clinical Benefits In Subtype Of Patients

By Vandana Singh
November 29, 2:21 PM
AbbVie Inc (NYSE: ABBV) announced topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type, 

ABBV

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is Bacterial Infection-Focused BiomX Stock Trading Lower Today?

By Vandana Singh
November 29, 1:00 PM
BiomX Inc (NYSE: PHGE) released safety and efficacy results from Part 2 of the Phase 1b/2a trial of BX004 for chronic pulmonary infections caused by Pseudomonas aeruginosa (P.

PHGE

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is Alzheimer’s-Focused BioVie Stock Trading Lower Today?

By Vandana Singh
November 29, 12:29 PM
BioVie Inc (NASDAQ: BIVI) shares are trading lower after the company released an analysis of unblinded, topline efficacy data from its Phase 3 trial of NE3107 for mild to 

BIVI

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

Counterfeit Ozempic Raises Alarms – Lebanon Reports Hypoglycemia Cases

By Vandana Singh
November 29, 11:17 AM
Lebanese health officials have reported eleven cases of severe hypoglycemia linked to suspected fake versions of Novo Nordisk A/S's (NYSE: NVO) 

LLY

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?

By Vandana Singh
November 29, 11:14 AM
Vivos Therapeutics Inc (NASDAQ: VVOS) received FDA 510(k) clearance for treating severe obstructive sleep apnea (OSA) in adults using the Vivos' removable CARE (Complete Airway Repositioning and/or Expansion) 

VVOS

Posts pagination

Previous 1 … 187 188 189 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service